These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 7618632)
21. The effect of probucol and vitamin E treatment on the oxidation of low-density lipoprotein and forearm vascular responses in humans. McDowell IF; Brennan GM; McEneny J; Young IS; Nicholls DP; McVeigh GE; Bruce I; Trimble ER; Johnston GD Eur J Clin Invest; 1994 Nov; 24(11):759-65. PubMed ID: 7890014 [TBL] [Abstract][Full Text] [Related]
22. Lovastatin versus bezafibrate for hyperlipemia treatment after heart transplantation. Hidalgo L; Zambrana JL; Blanco-Molina A; López-Granados A; Concha M; Casares J; Jiménez-Pérez J; López-Miranda J; Pérez-Jiménez F J Heart Lung Transplant; 1995; 14(3):461-7. PubMed ID: 7654731 [TBL] [Abstract][Full Text] [Related]
23. Moderate dose, three-drug therapy with niacin, lovastatin, and colestipol to reduce low-density lipoprotein cholesterol <100 mg/dl in patients with hyperlipidemia and coronary artery disease. Brown BG; Bardsley J; Poulin D; Hillger LA; Dowdy A; Maher VM; Zhao XQ; Albers JJ; Knopp RH Am J Cardiol; 1997 Jul; 80(2):111-5. PubMed ID: 9230143 [TBL] [Abstract][Full Text] [Related]
24. Relative effectiveness of niacin and lovastatin for treatment of dyslipidemias in a health maintenance organization. O'Connor PJ; Rush WA; Trence DL J Fam Pract; 1997 May; 44(5):462-7. PubMed ID: 9152263 [TBL] [Abstract][Full Text] [Related]
25. Low-dose lovastatin in hyperlipidemic kidney graft recipients with cyclosporine A. Traindl O; Reading S; Franz M; Falger S; Klauser R; Gisinger J; Widhalm K; Kovarik J Transplant Proc; 1992 Dec; 24(6):2745-7. PubMed ID: 1465924 [No Abstract] [Full Text] [Related]
26. A multicenter comparative trial of lovastatin and pravastatin in the treatment of hypercholesterolemia. The Lovastatin Pravastatin Study Group. Am J Cardiol; 1993 Apr; 71(10):810-5. PubMed ID: 8456759 [TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain. Plans-Rubió P Am J Cardiovasc Drugs; 2006; 6(3):177-88. PubMed ID: 16780391 [TBL] [Abstract][Full Text] [Related]
28. [Comparison between lovastatin and gemfibrozil in treatment of primary hyperlipidemias]. Bertolami MC; Martinez TL; Faludi AA; Pinto LE; Melo RS; Bismarck ZF; Batlouni M Arq Bras Cardiol; 1991 May; 56(5):407-12. PubMed ID: 1823741 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of extended-release niacin with lovastatin for hypercholesterolemia: assessing all reasonable doses with innovative surface graph analysis. Insull W; McGovern ME; Schrott H; Thompson P; Crouse JR; Zieve F; Corbelli J Arch Intern Med; 2004 May; 164(10):1121-7. PubMed ID: 15159270 [TBL] [Abstract][Full Text] [Related]
30. Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments. Lane DM; Alaupovic P; Knight-Gibson C; Dudley VS; Laughlin LO Am J Cardiol; 1995 Jun; 75(16):1124-9. PubMed ID: 7762498 [TBL] [Abstract][Full Text] [Related]
31. A comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia. D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC Am J Cardiol; 1992 Jan; 69(1):28-34. PubMed ID: 1729864 [TBL] [Abstract][Full Text] [Related]
32. Contrasting effects of lovastatin and cholestyramine on low-density lipoprotein cholesterol and 24-hour urinary mevalonate excretion in patients with heterozygous familial hypercholesterolemia. Pappu AS; Illingworth DR J Lab Clin Med; 1989 Nov; 114(5):554-62. PubMed ID: 2809398 [TBL] [Abstract][Full Text] [Related]
33. Treatment of hyperlipidemic kidney graft recipients with lovastatin: effect on LDL-cholesterol and lipoprotein (a). Traindl O; Reading S; Franz M; Watschinger B; Klauser R; Pidlich H; Widhalm K; Pohanka E; Kovarik J Nephron; 1992; 62(4):394-8. PubMed ID: 1300434 [TBL] [Abstract][Full Text] [Related]
34. Clinical efficacy of cerivastatin: phase IIa dose-ranging and dose-scheduling studies. Hunninghake DB Am J Cardiol; 1998 Aug; 82(4B):26J-31J. PubMed ID: 9737643 [TBL] [Abstract][Full Text] [Related]
36. Niacin-ER and lovastatin treatment of hypercholesterolemia and mixed dyslipidemia. Yim BT; Chong PH Ann Pharmacother; 2003 Jan; 37(1):106-15. PubMed ID: 12503944 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and tolerability of lovastatin in elderly hypercholesterolemic patients. D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC Clin Ther; 1992; 14(1):68-76. PubMed ID: 1576628 [TBL] [Abstract][Full Text] [Related]
38. [Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study]. Forti N; Ramires JA Arq Bras Cardiol; 1991 Sep; 57(3):253-61. PubMed ID: 1824203 [TBL] [Abstract][Full Text] [Related]
39. Postmarketing analysis of lovastatin use in the VA Northern California System of Clinics: a retrospective, computer-based study. Swislocki AL; Lin K; Cogburn D; Fann KY; Khuu DT; Noth RH Am J Manag Care; 1997 Oct; 3(10):1537-45. PubMed ID: 10178460 [TBL] [Abstract][Full Text] [Related]
40. Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): efficacy and tolerability of long-term treatment with lovastatin in women. Clearfield M; Downs JR; Weis S; Whitney EJ; Kruyer W; Shapiro DR; Stein EA; Langendorfer A; Beere PA; Gotto AM J Womens Health Gend Based Med; 2001 Dec; 10(10):971-81. PubMed ID: 11788107 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]